ReWalk Robotics. Ltd. announced that the Board has approved the appointment of Joseph Turk, Jr. to the Board of Directors, effective April 20, 2022. After initiating his career at McKinsey and Company, Mr. Turk has assembled an extensive history in the medical device industry beginning with his role as Director of New Business Development at Boston Scientific.

Subsequently, he held multiple roles at NxStage Medical, including President, where he led all commercialization activities including securing favorable Medicare payment policies; overseeing all commercial functions for the implementation and growth of their key products; and coordinating key M&A efforts for building the company. Currently, he is an Executive Vice President at Fresenius Medical Care North America (FMC-NA) and the President of the Renal Therapies Group. Prior to that he was the President of FMC-NA's Home and Critical Care Therapies efforts.